Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

The share price of Lupin Ltd. gained 1.02 per cent to Rs 2275.3 at 10:51AM (IST) in Tuesday's trade. The counter has hit a ...

Lupin Lodge, a historic naturist resort in the heart of Silicon Valley, recently celebrated its 90th anniversary with events ...

Lupin is preparing the launch of PredForte, having a market of $200 million with 180 days competitive generic therapy (CGT) ...

Fiat partners with Lupin the Third for three limited-edition Fiat models for real-life getaway drivers, alongside all-new ...

Lupin is launching mirabegron ER tablets, 50 mg, which is a generic of Astellas Pharma’s Myrbetriq. Myrbetriq is used to ...

Lupin shares have yielded a return of 74.72 per cent year-to-date, while the Sensex, on the other hand, has advanced 13.72 ...

The approval granted by the US Food and Drug Administration (USFDA) is for Mirabegron extended-release tablets of strength 50 ...

Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a ...

Nilesh Gupta, managing director, Lupin. G lobal pharma leader Lupin has a robust pipeline lined up for FY25—over 25+ projects ...

Sunsure will supply solar power to Lupin’s Tarapur facility in India from its 100 MW (150 MWp) solar plant in Solapur ...

Global pharma major Lupin Limited (Lupin) announced the launch of the United States Food and Drug Administration (FDA) approved mirabegron extended-release tablets, 50 mg, in US. Mirabegron ...